12Mar
05Mar
New Episode of Never a Dull Moment – The CFO
🎙️ Never a Dull Moment podcast has released a new episode! 🎙️ In this conversation, host Ziad Henry Moukheiber chats with guest Michael Bayer, CFO of one of Boston Harbor Angels portfolio companies Wasabi Technologies. This fascinating discussion is kicked off with Michael's description of a CFO as a storyteller. Tune in to hear more about about how the role of CFO has evolved!
04Mar
The Active Archive Alliance Welcomes Wasabi Technologies to the Organization
The Active Archive Alliance today announced that Wasabi Technologies, the hot cloud storage company, has joined the organization. The Active Archive Alliance is a collaboration of industry-leading storage systems and software vendors that collectively support and promote the use of active archives in providing modern solutions for today's data growth challenges. "Wasabi plays an important role in providing fully integrated solutions with AI enhancements, security and affordability built in – furthering the use of active archives for intelligent data management."...
19Feb
Akston Named Best Start-Up for 2024 in the S&P Global Animal Health Awards
Akston, the biotech built for pets, has been awarded the Best Start-Up of 2024 by S&P Global Animal Health at the Animal Health, Nutrition, and Technology Innovation Europe 2025 conference in London. The award was presented by Joseph Harvey, Editor, S&P Global Animal Health, and accepted by Akston CEO, Todd Zion. Read more >>
17Feb
Light Within the Black Hole of Concussion Therapeutics
Last September, the Fédération Internationale de Football Association (FIFA) and the World Health Organization launched the “Suspect and Protect” concussion awareness campaign. In the past few years, the U.S. Department of Defense, the National Hockey League, and the National Football League each introduced plans to minimize concussions, including updating their concussion protocols. And large pharmaceutical companies have done…little. For companies active in this space, their slow progress may be more related to investors’ misperceptions of the topic than the science itself....
16Feb
Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate
On Friday, Corbus Pharmaceuticals Holdings, Inc. announced that data from its US and UK first-in-human dose escalation clinical study of CRB-701 (SYS6002) were presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium. The Phase 1 Western dose escalation study enrolled participants with metastatic urothelial cancer (mUC) and other solid tumors associated with Nectin-4 expression. These included several tumor types not previously explored in China. Read more >>
13Feb
Candidly Reports Near $2 Billion in Student Debt Impact, Unveils 2024 Annual Impact Report
Candidly, the market's only AI-driven student debt and savings optimization platform, today announced milestone achievements in its 2024 Annual Impact Report, including $1.8 billion in projected student debt impact and over 200,000 years saved off of student debt repayment. Read more >>
13Feb
Aras to Celebrate 25 Years of Innovation at ACE 2025 in Boston
...2025 marks a major milestone as Aras celebrates 25 years of continuous innovation while looking ahead to AI-driven PLM, advanced digital thread strategies, and scalable transformation initiatives. ACE 2025 will explore how today’s industry pioneers are establishing seamless digital threads across the entire lifecycle to enhance resilience, efficiency, and long-term competitiveness. Read more >>
12Feb
DetraPel, Inc. Selects Charlotte for Headquarters, Manufacturing
DetraPel, Inc., a clean-tech advanced materials company, has chosen to relocate its headquarters and advanced manufacturing operations to Charlotte. The company will invest $3.5 million and bring more than 30 new jobs to Southwest Charlotte. Read more >>
12Feb